Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mitsugi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Oncology|May 18, 2011
Simple and efficient chemosensitivity assay for human primary tumor-cells using contact-sensitive microtiter platesK Mitsugi, S Nakano, M Nakayama, et al.
Journal of Neuroimmunology|March 1, 1992
Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSPM Nakamura, Y Itoyama, M Kuroki, et al.
ESMO Open|March 21, 2021
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7T Takahashi, K Yamazaki, E Oki, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)T Shirakawa, M Shimokawa, T Otsuka, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Oncology|May 18, 2011
Simple and efficient chemosensitivity assay for human primary tumor-cells using contact-sensitive microtiter platesK Mitsugi, S Nakano, M Nakayama, et al.
Journal of Neuroimmunology|March 1, 1992
Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSPM Nakamura, Y Itoyama, M Kuroki, et al.
ESMO Open|March 21, 2021
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7T Takahashi, K Yamazaki, E Oki, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)T Shirakawa, M Shimokawa, T Otsuka, et al.
Pageof 3